TotalCare SpO2RT2 bed. Product Usage: Bed, flotation therapy, powered bed may be used in a variety of settings including, but not limited to, acute care, including critical care, step down/progressive care, medical/surgical, high acuity sub-acute care, post anesthesia care unit (PACU), and sections of the emergency department (ED). The TotalCare SpO2RT® 2 Bed System is capable of being used with a broad patient population as determined appropriate by the caregiver or institution.
Publicado el 20 de marzo de 2013 · Inicio del retiro: 26 de febrero de 2013
Resumen
FDA registra el retiro Z-0949-2013 de dispositivos médicos de Clase II, publicado el 20 de marzo de 2013 e iniciado el 26 de febrero de 2013. Empresa responsable: Hill-Rom, Inc.; Estado: Finalizado; Cantidad reportada: 309; Lote: S/N between N230AM1358 & O023AM3687. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
In certain situations a software problem with the TotalCare SpO2RT® 2 bed may occur that can lead to inadvertent loss of sufficient surface cushion pressure to adequately support the patient. This may increase the likelihood of skin irritation for patients at higher risk of developing pressure-related skin conditions. A correction to the software program is currently being developed and tested,
Qué hacer
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Hill-Rom, Inc.
- Distribuidor
- USA Nationwide Distribution including the state of Canada
- Lote
- S/N between N230AM1358 & O023AM3687.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAProgressa Bed, Catalog No. P7500 - Product Usage: intended to be used to treat or prevent pulmonary or other5 de agosto de 2020
- FDASteriseal-Cannula Ophthalmic; Bi-Manual Irrigating/Aspirating Handpiece.1 de julio de 2015
- FDAViking M, L, and XL Mobile Lifts. Non-AC-powered patient lift.24 de junio de 2015
- FDAAffinity® Four Birthing Bed, Product Usage: Product is intended to be used as birthing beds for women of child10 de septiembre de 2014
- FDASiemens Somatom CTs equipped with software syngo CT2010A, syngo CT2010B, syngo CT2011A and CT2012B. Computed20 de marzo de 2013
- FDABrilliance 64 and Ingenuity Computed Tomography X-Ray Systems The Brilliance 64 and Ingenuity CT are whole20 de marzo de 2013
Preguntas sobre este retiro
¿TotalCare SpO2RT2 bed. Product Usage: Bed, flotation therapy, powered bed may be used in a variety of settings including, but not limited to, acute care, including critical care, step down/progressive care, medical/surgical, high acuity sub-acute care, post anesthesia care unit (PACU), and sections of the emergency department (ED). The TotalCare SpO2RT® 2 Bed System is capable of being used with a broad patient population as determined appropriate by the caregiver or institution. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0949-2013 el 20 de marzo de 2013. Peligro reportado: In certain situations a software problem with the TotalCare SpO2RT® 2 bed may occur that can lead to inadvertent loss of sufficient surface cushion pressure to adequately support the patient. This may increase the likelihood of skin irritation for patients at higher risk of developing pressure-related skin conditions. A correction to the software program is currently being developed and tested,
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit